Triple
T12804175
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biotechnology Heritage Award |
E306100
|
entity |
| Predicate | formerName |
P65
|
FINISHED |
| Object |
Biotechnology Industry Organization
The Biotechnology Industry Organization, now known as the Biotechnology Innovation Organization (BIO), is a major trade association representing biotechnology companies, academic institutions, and related organizations worldwide.
|
E1004615
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Biotechnology Industry Organization | Statement: [Biotechnology Heritage Award, formerName, Biotechnology Industry Organization]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Biotechnology Industry Organization Context triple: [Biotechnology Heritage Award, formerName, Biotechnology Industry Organization]
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
Foresight Institute
Foresight Institute is a nonprofit think tank and advocacy organization focused on advancing transformative technologies such as nanotechnology, biotechnology, and artificial intelligence for the long-term benefit of humanity.
-
E.
US-India Business Council
The US-India Business Council is a leading bilateral trade association that promotes commercial and strategic ties between the United States and India by representing major companies and facilitating policy dialogue.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Biotechnology Industry Organization Triple: [Biotechnology Heritage Award, formerName, Biotechnology Industry Organization]
Generated description
The Biotechnology Industry Organization, now known as the Biotechnology Innovation Organization (BIO), is a major trade association representing biotechnology companies, academic institutions, and related organizations worldwide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Biotechnology Industry Organization Target entity description: The Biotechnology Industry Organization, now known as the Biotechnology Innovation Organization (BIO), is a major trade association representing biotechnology companies, academic institutions, and related organizations worldwide.
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
-
C.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
D.
Foresight Institute
Foresight Institute is a nonprofit think tank and advocacy organization focused on advancing transformative technologies such as nanotechnology, biotechnology, and artificial intelligence for the long-term benefit of humanity.
-
E.
US-India Business Council
The US-India Business Council is a leading bilateral trade association that promotes commercial and strategic ties between the United States and India by representing major companies and facilitating policy dialogue.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d7bdf366888190a8cccb982606889c |
completed | April 9, 2026, 2:55 p.m. |
| NER | Named-entity recognition | batch_69d96e7e3be48190ba9159c9f1ac2ccd |
completed | April 10, 2026, 9:41 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f68ec463f08190822e5235362cf584 |
completed | May 2, 2026, 11:54 p.m. |
| NEDg | Description generation | batch_69f6908cb8ec8190855b217c13a51f16 |
completed | May 3, 2026, 12:02 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69f6917688508190ae5a64494eaadce7 |
completed | May 3, 2026, 12:06 a.m. |
Created at: April 9, 2026, 5:30 p.m.